Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia

Clinical trial NCT01670084 · WITHDRAWN

Trial details

NCT number: NCT01670084
Sponsor: Mayo Clinic
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

B-cell Adult Acute Lymphoblastic Leukemia Blastic Phase Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia

Start date: 2012-12-01
Primary completion: 2015-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.